Patent classifications
C12Q1/22
Indicating Devices Based onEtching of Metals
Compositions, devices and processes related to etching of a very thin layer or fine particles of a metal are disclosed for monitoring a variety of parameters, such as time, temperature, time-temperature, thawing, freezing, microwave, humidity, ionizing radiation, sterilization and chemicals. These devices have capabilities of producing a long and sharp induction period of an irreversible visual change. The devices are composed of an indicator comprising a very thin layer of a metal and an activator, e.g., a reactant, such as water, water vapor, an acid, a base, oxidizing agent or their precursors, which is capable of reacting with the said indicator. Ink formulations composed of a metal powder and a proper activator can be used for monitoring several sterilization processes, such as sterilization with steam. When water is used as an activator, a thin layer of metals, such as that of aluminum can be used as steam sterilization or humidity indicator.
Indicating Devices Based onEtching of Metals
Compositions, devices and processes related to etching of a very thin layer or fine particles of a metal are disclosed for monitoring a variety of parameters, such as time, temperature, time-temperature, thawing, freezing, microwave, humidity, ionizing radiation, sterilization and chemicals. These devices have capabilities of producing a long and sharp induction period of an irreversible visual change. The devices are composed of an indicator comprising a very thin layer of a metal and an activator, e.g., a reactant, such as water, water vapor, an acid, a base, oxidizing agent or their precursors, which is capable of reacting with the said indicator. Ink formulations composed of a metal powder and a proper activator can be used for monitoring several sterilization processes, such as sterilization with steam. When water is used as an activator, a thin layer of metals, such as that of aluminum can be used as steam sterilization or humidity indicator.
APPARATUS AND METHOD FOR ANALYZING BIOLOGICAL INDICATORS
A biological indicator analyzer includes a plurality of wells, a plurality of organism detector features, and a user input feature such as a touch screen. Each well is configured to receive a respective biological indicator. Each organism detector feature is configured to detect whether a biological indicator disposed in a corresponding well of the plurality of wells contains a living organism. The touch screen is configured to receive user input and provide information to the user indicating a status of biological indicator analysis. The biological indicator analyzer may be used to analyze a biological indicator that was positioned in a sterilization chamber of a sterilizing cabinet along with at least one medical device that is to be sterilized. The analysis may indicate whether the sterilization cycle in the sterilization chamber as successful.
APPARATUS AND METHOD FOR ANALYZING BIOLOGICAL INDICATORS
A biological indicator analyzer includes a plurality of wells, a plurality of organism detector features, and a user input feature such as a touch screen. Each well is configured to receive a respective biological indicator. Each organism detector feature is configured to detect whether a biological indicator disposed in a corresponding well of the plurality of wells contains a living organism. The touch screen is configured to receive user input and provide information to the user indicating a status of biological indicator analysis. The biological indicator analyzer may be used to analyze a biological indicator that was positioned in a sterilization chamber of a sterilizing cabinet along with at least one medical device that is to be sterilized. The analysis may indicate whether the sterilization cycle in the sterilization chamber as successful.
SELF-CONTAINED BIOLOGICAL INDICATOR
A biological sterilization indicator is disclosed that in some embodiments comprises a housing having a first enclosure and a second enclosure, an ampule containing a liquid growth medium, and an insert disposed at least partially in the first enclosure. A portion of the ampule may be disposed inside the first enclosure. The insert may have a platform including a top surface, an abutment surface, and a side surface, as well as a first void disposed in the platform and configured to allow passage of a first volume of the liquid growth medium into the second enclosure and a second void disposed through at least a portion of the side surface and configured to allow passage of a second volume of the liquid growth medium into the second enclosure. The second void of the insert may be an angled cut through the abutment surface and the side surface, which may be disposed entirely beneath the top surface. In some embodiments, stress concentrators and other features are included to reduce the force required to activate the biological sterilization indicator.
SELF-CONTAINED BIOLOGICAL INDICATOR
A biological sterilization indicator is disclosed that in some embodiments comprises a housing having a first enclosure and a second enclosure, an ampule containing a liquid growth medium, and an insert disposed at least partially in the first enclosure. A portion of the ampule may be disposed inside the first enclosure. The insert may have a platform including a top surface, an abutment surface, and a side surface, as well as a first void disposed in the platform and configured to allow passage of a first volume of the liquid growth medium into the second enclosure and a second void disposed through at least a portion of the side surface and configured to allow passage of a second volume of the liquid growth medium into the second enclosure. The second void of the insert may be an angled cut through the abutment surface and the side surface, which may be disposed entirely beneath the top surface. In some embodiments, stress concentrators and other features are included to reduce the force required to activate the biological sterilization indicator.
SURROGATE VIRUS ASSAYS AND METHODS
A method for monitoring the presence or absence of a megavirus in animal feed, an animal feed ingredient, or an animal product uses a surrogate virus assay. The surrogate virus assay generally includes, inoculating the animal feed, animal feed ingredient, or animal product with a surrogate virus as a proxy for the megavirus, subjecting the animal feed, animal feed ingredient, or animal product to a treatment that inactivates the megavirus and the surrogate virus, waiting a predetermined period of time, and determining the presence or absence of the surrogate virus in the animal feed, animal feed ingredient, or animal product, thereby monitoring the presence or absence of the megavirus in the animal feed, animal feed ingredient, or animal product.
SURROGATE VIRUS ASSAYS AND METHODS
A method for monitoring the presence or absence of a megavirus in animal feed, an animal feed ingredient, or an animal product uses a surrogate virus assay. The surrogate virus assay generally includes, inoculating the animal feed, animal feed ingredient, or animal product with a surrogate virus as a proxy for the megavirus, subjecting the animal feed, animal feed ingredient, or animal product to a treatment that inactivates the megavirus and the surrogate virus, waiting a predetermined period of time, and determining the presence or absence of the surrogate virus in the animal feed, animal feed ingredient, or animal product, thereby monitoring the presence or absence of the megavirus in the animal feed, animal feed ingredient, or animal product.
METHOD FOR INACTIVATING ZIKA VIRUS AND RELATED METHODS
The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation and to a method for determining the residual formaldehyde content in a pharmaceutical composition comprising an inactivated virus.
METHOD FOR INACTIVATING ZIKA VIRUS AND RELATED METHODS
The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation and to a method for determining the residual formaldehyde content in a pharmaceutical composition comprising an inactivated virus.